Vir Biotechnology, Inc. (VIR)

9.55 +0.45 (+4.95%) USD  |  NASDAQ  |  Mar 06, 16:00
9.52 -0.03 (-0.31%) After-Hours: 20:00
More

Vir Biotechnology Payables and Accrued Expenses (Quarterly)

Payables and Accrued Expenses (Quarterly) Chart

View Payables and Accrued Expenses (Quarterly) for VIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Payables and Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Payables and Accrued Expenses (Quarterly) Benchmarks

View Payables and Accrued Expenses (Quarterly) Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Xeris Biopharma Holdings, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Sensei Biotherapeutics, Inc. Upgrade